EUVIMEDEUVIMED entdecken
Crossref

Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States

Abhisheak Sharma iD, Kirsten E Smith, Michelle A Kuntz iD, Erin C Berthold iD, Omar I Elashkar, Nicholas Guadagnoli, Siva Rama Raju Kanumuri iD, Sushobhan Mukhopadhyay, Leigh V Panlilio, David H Epstein, Christopher R McCurdy

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Abhisheak Sharma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Mitragyna, Secologanin Tryptamine Alkaloids, Plant Extracts, Alkaloids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previously, we used ecological momentary assessment (EMA) to evaluate motivations and temporal patterns of kratom use for 15 days among US adult kratom consumers ( N = 357). Here we present the content analyses of the products used during that nationwide study, with quantification of 10 kratom alkaloids. The samples ( N = 341) were primarily whole‐leaf products, not extracts, and were similar to each other in their alkaloid composition, closely matching the chromatographic‐mass spectrometry fingerprint expected for Mitragyna speciosa leaf material. We found no evidence of adulteration with illicit or prescription drugs. With participants' self‐reported data on kratom amount per use, we calculated mitragynine intake per use: mean 31.3 mg and median 25.4 mg (range 2.0–205.9 mg). With self‐reported data on frequency, we calculated mitragynine intake per day, it ranged from 78.3 to 134.6 mg (mean) or 50.8 to 101.6 mg (median). This is the most comprehensive analysis of US whole‐leaf kratom products to date. The coupling of self‐report and product sample‐analysis data to quantify daily alkaloid intake is foundational for designing controlled clinical trials of kratom in healthy volunteers. These findings on kratom products' chemical composition and daily kratom alkaloid consumption can also inform clinicians, policymakers, and consumers, particularly for whole‐leaf material.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitragynaSecologanin Tryptamine AlkaloidsPlant ExtractsAlkaloidsHumansUnited StatesPlant LeavesAdultMaleFemaleSelf ReportMiddle AgedYoung Adult

Stichwörter der Autor:innen

UPLC‐MS/MSalkaloidskratommitragynine

Substanzen

Secologanin Tryptamine AlkaloidsmitragyninePlant ExtractsAlkaloids

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Translational Drug Development Core, Clinical and Translational Sciences Institute, University of Florida, Gainesville, Florida, USA.
  • Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Real-World Assessment, Prediction, and Treatment Unit, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland, USA.

ORCID-Profile: Abhisheak Sharma, Michelle A Kuntz, Erin C Berthold, Siva Rama Raju Kanumuri

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Sharma, A., Smith, K. E., Kuntz, M. A., Berthold, E. C., Elashkar, O. I., Guadagnoli, N., Kanumuri, S. R. R., Mukhopadhyay, S., Panlilio, L. V., Epstein, D. H., & McCurdy, C. R. (2025). Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States. Drug Testing and Analysis. https://doi.org/10.1002/dta.3906

Vancouver

Sharma A, Smith KE, Kuntz MA, Berthold EC, Elashkar OI, Guadagnoli N, et al. Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States. Drug Testing and Analysis. 2025. doi:10.1002/dta.3906

BibTeX
@article{Sharma2025,
  author = {Sharma, Abhisheak and Smith, Kirsten E and Kuntz, Michelle A and Berthold, Erin C and Elashkar, Omar I and Guadagnoli, Nicholas and Kanumuri, Siva Rama Raju and Mukhopadhyay, Sushobhan and Panlilio, Leigh V and Epstein, David H and McCurdy, Christopher R},
  title = {Chemical Analysis and Alkaloid Intake for Kratom Products Available in the United States},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3906}
}
Kostenlos starten →